Nouveau Life Pharmaceuticals, Inc.
NOUV · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2008 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | – | – | $8 | $0 |
| Short-Term Investments | – | – | $0 | $0 |
| Receivables | – | – | $0 | $0 |
| Inventory | – | – | $0 | $0 |
| Other Curr. Assets | – | – | $0 | $0 |
| Total Curr. Assets | – | – | $8 | $0 |
| Property Plant & Equip (Net) | – | – | $0 | $748 |
| Goodwill | – | – | $0 | $0 |
| Intangibles | – | – | $0 | $421 |
| Long-Term Investments | – | – | $0 | $0 |
| Tax Assets | – | – | $0 | $0 |
| Other NC Assets | – | – | $0 | $0 |
| Total NC Assets | – | – | $0 | $1,169 |
| Other Assets | – | – | $0 | $0 |
| Total Assets | – | – | $8 | $1,170 |
| Liabilities | – | – | – | – |
| Payables | – | – | $0 | $217 |
| Short-Term Debt | – | – | $0 | $60 |
| Tax Payable | – | – | $0 | $0 |
| Deferred Revenue | – | – | $0 | $34 |
| Other Curr. Liab. | – | – | $2 | $588 |
| Total Curr. Liab. | – | – | $2 | $900 |
| LT Debt | – | – | $0 | $5 |
| Deferred Rev, NC | – | – | $0 | $0 |
| Deferred Tax Liab, NC | – | – | $0 | $0 |
| Other NC Liab. | – | – | $101 | $223 |
| Total NC Liab. | – | – | $101 | $228 |
| Other Liabilities | – | – | $0 | $0 |
| Cap. Leases | – | – | $0 | $0 |
| Total Liabilities | – | – | $103 | $1,127 |
| Equity | – | – | – | – |
| Pref Stock | – | – | $0 | $0 |
| Common Stock | – | – | $666 | $30 |
| Retained Earnings | – | – | -$1,124 | -$3,163 |
| AOCI | – | – | $0 | $739 |
| Other Equity | – | – | $363 | $2,437 |
| Total Equity | – | – | -$96 | $43 |
| Supplemental Information | – | – | – | – |
| Minority Interest | – | – | $0 | $0 |
| Total Liab. & Tot. Equity | – | – | $8 | $1,170 |
| Net Debt | $0 | $0 | -$8 | $64 |